Topics & Speakers
- Walter J. Putschar Lecture: Problems of
Prognostication in Soft Tissue Tumors
- Walter J. Putschar Lecture: The Differential
Diagnosis of Myxoid Soft Tissue Tumors
Christopher D.M. Fletcher, MD
- Rhabdomyosarcoma: Current Morphologic and
Molecular Classification
Antonio R. Perez-Atayde, MD
- Skeletal System - From Conception to Puberty
Alan L. Schiller, MD
- Osteoblasts and Osteoclasts: Friends and Foes
- Differential Diagnosis of Matrix Forming Tumors—
Bone Forming Neoplasms
- Small Round Cell Tumors of Bone
- Pseudosarcomas of Soft Tissue
Andrew E. Rosenberg, MD
- Differential Diagnosis of Matrix Forming Tumors—
Cartilage Forming Neoplasms
- Diseases of the Synovium
G. Petur Nielsen, MD
|
- Soft Tissue Tumors of the Lower Genital Tract
Marisa R. Nucci, MD
- Update on Peripheral Nerve Tumors
Briana C. Gleason, MD
- New Entities in Soft Tissue Pathology
Alessandra F. Nascimento, MD
- Practical Applications of Molecular Diagnostics in
Bone and Soft Tissue Tumors
Jonathan A. Fletcher, MD
- Cytogenetics of Bone and Soft Tissue Tumors
Paola Dal Cin, PhD
- Myoepithelial Tumors and Their Mimics
Jason L. Hornick, MD, PhD
|
Course Directors
Andrew E. Rosenberg, MD
Associate Professor of Pathology
Christopher D.M. Fletcher, MD
Professor of Pathology |
|
Harvard Faculty |
|
Paola Dal Cin, PhD
Associate Professor of Pathology
Jonathan A. Fletcher, MD
Associate Professor of Pathology
Associate Professor of Pediatrics
Briana C. Gleason, MD
Instructor in Pathology
Jason L. Hornick, MD, PhD
Assistant Professor in Pathology
|
Alessandra F. Nascimento, MD
Assistant Professor in Pathology
G. Petur Nielsen, MD
Associate Professor of Pathology
Marisa R. Nucci, MD
Associate Professor of Pathology
Antonio R. Perez-Atayde, MD
Associate Professor of Pathology |
Guest Faculty
Alan L. Schiller, MD
Irene Heinz and John LaPorte Given Professor
Chairman of the Department of Pathology
Mount Sinai School of Medicine
New York City, NY |
|
Learning Objectives
After viewing this activity, participants will be able to:
- Understand the process of growth and development of the skeletal system and the organic and inorganic components of which it is comprised
- Increase knowledge of the diagnostic criteria of a variety of primary bone tumors
- Increase knowledge of the diagnostic criteria of a variety of primary soft tissue tumors and tumor-like processes
- Understand the role of molecular biology and cytogenetics in the diagnosis of bone and soft tissue tumors
Accreditation Statement
Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical
education for physicians.
Designation
Harvard Medical School designates this educational activity for a maximum of 11.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Release date: December 1, 2008. Credits expire: December 1, 2010.
CME credit is obtained upon successful completion of an activity post-test, as well as payment of a $30 processing fee.
Disclosure Statement
Harvard Medical School has long held the standard that its continuing medical education courses be free of commercial bias. Now, in accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council on Continuing Medical Education, speakers and their spouses/partners, and planners have been asked to disclose any relationship they have to companies producing pharmaceuticals, medical equipment, prosthesis, etc. that might be germane to the content of their lectures. Please note that now in accordance with recent policies from the ACCME, relationships of the person involved in the CME activity must include financial relationships of a spouse or partner.
In addition, faculty have been asked to describe any off label uses, they will discuss, of pharmaceuticals and devices for investigational or non-FDA approved purposes.
Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide the course director and registrants with information that might be of potential importance to their evaluation of a given talk. The full disclosure of faculty is listed in the syllabus.
|